E J McFarland

Summary

Affiliation: University of Colorado Health Sciences Center
Country: USA

Publications

  1. ncbi Clonal CD8+ T cell expansions in peripheral blood from human immunodeficiency virus type 1-infected children
    Elizabeth J McFarland
    Division of Pediatric Infectious Diseases, University of Colorado Health Sciences Center, Denver 80262, USA
    J Infect Dis 186:477-85. 2002
  2. ncbi Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine
    E J McFarland
    Department of Pediatrics, University of Colorado Health Science Center, Denver, CO 80262, USA
    J Infect Dis 184:1331-5. 2001
  3. ncbi HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers
    Elizabeth J McFarland
    Department of Pediatric Infectious Diseases, University of Colorado Health Sciences Center, Denver Colorado, USA
    AIDS 20:1481-9. 2006
  4. ncbi Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women
    C K Cunningham
    Department of Pediatrics, State University of New York, Upstate Medical University, Syracuse, NY 13210, USA
    Clin Infect Dis 32:801-7. 2001
  5. ncbi Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children
    T I Miller
    Department of Pediatrics, Division of Pediatric Clinical Research, Miller School of Medicine at the University of Miami, Miami, FL, USA
    HIV Med 13:264-75. 2012
  6. ncbi Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women
    Daniel C Johnson
    Sinai Children s Hospital and Rosalind Franklin University of Medicine and Science, North Chicago, IL 60608, USA
    J Infect Dis 192:2129-33. 2005
  7. ncbi Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected children
    Stuart E Starr
    Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, USA
    AIDS 17:2181-9. 2003
  8. ncbi Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study
    William T Shearer
    Baylor College of Medicine, Houston, Tex, USA
    J Allergy Clin Immunol 112:973-80. 2003
  9. ncbi Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge
    Carlos M Pérez-Vélez
    Department of Pediatrics, Section of Infectious Diseases, University of Colorado School of Medicine, and The Children s Hospital, Denver, Colorado 80218, USA
    Clin Infect Dis 45:950-7. 2007

Collaborators

Detail Information

Publications9

  1. ncbi Clonal CD8+ T cell expansions in peripheral blood from human immunodeficiency virus type 1-infected children
    Elizabeth J McFarland
    Division of Pediatric Infectious Diseases, University of Colorado Health Sciences Center, Denver 80262, USA
    J Infect Dis 186:477-85. 2002
    ..Children with expansions were not more likely to have increased numbers of CD8(+) T cells, a finding consistent with the possibility that the CD8(+) TCR repertoire has limited diversity...
  2. ncbi Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine
    E J McFarland
    Department of Pediatrics, University of Colorado Health Science Center, Denver, CO 80262, USA
    J Infect Dis 184:1331-5. 2001
    ..These results provide support for further studies of vaccine strategies to prevent mother-to-infant HIV-1 transmission...
  3. ncbi HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers
    Elizabeth J McFarland
    Department of Pediatric Infectious Diseases, University of Colorado Health Sciences Center, Denver Colorado, USA
    AIDS 20:1481-9. 2006
    ..This study evaluated the safety and immunogenicity of ALVAC HIV-1 vaccine with and without a subunit envelope boost in infants born to HIV-1-infected women...
  4. ncbi Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women
    C K Cunningham
    Department of Pediatrics, State University of New York, Upstate Medical University, Syracuse, NY 13210, USA
    Clin Infect Dis 32:801-7. 2001
    ..Thus, both vaccines were safe and well tolerated in neonates, and there was no evidence of accelerated immunologic decline in HIV-infected infants...
  5. ncbi Metabolic abnormalities and viral replication are associated with biomarkers of vascular dysfunction in HIV-infected children
    T I Miller
    Department of Pediatrics, Division of Pediatric Clinical Research, Miller School of Medicine at the University of Miami, Miami, FL, USA
    HIV Med 13:264-75. 2012
    ....
  6. ncbi Safety and immunogenicity of an HIV-1 recombinant canarypox vaccine in newborns and infants of HIV-1-infected women
    Daniel C Johnson
    Sinai Children s Hospital and Rosalind Franklin University of Medicine and Science, North Chicago, IL 60608, USA
    J Infect Dis 192:2129-33. 2005
    ..33) TCID(50) vaccine formulation). Rare mucosal immunoglobulin A responses and no measurable vaccine-elicited serum antibodies were detected. In children, vCP205 appeared to be safe and immunogenic...
  7. ncbi Phase I/II trial of intravenous recombinant interleukin-2 in HIV-infected children
    Stuart E Starr
    Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, USA
    AIDS 17:2181-9. 2003
    ..Controlled trials of rIL-2 in this patient population are warranted...
  8. ncbi Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study
    William T Shearer
    Baylor College of Medicine, Houston, Tex, USA
    J Allergy Clin Immunol 112:973-80. 2003
    ..This study's findings will also prove invaluable in interpreting the immune changes in children with many other chronic diseases, such as primary immunodeficiency, malignancy, rheumatoid arthritis, and asthma...
  9. ncbi Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge
    Carlos M Pérez-Vélez
    Department of Pediatrics, Section of Infectious Diseases, University of Colorado School of Medicine, and The Children s Hospital, Denver, Colorado 80218, USA
    Clin Infect Dis 45:950-7. 2007
    ..Large epidemics of EV71 infection have been reported worldwide...